Albireo Pharma, Inc. Made Headway

Mon, Jan 09, 2023 at 07:02 PM
Albireo Pharma, Inc. Made Headway

Albireo Pharma, Inc. (ALBO:NASDAQ) jumped higher at $43.85, representing a gain of 92.2%. On Mon, Jan 09, 2023, ALBO:NASDAQ hit a New 2-Week High of $43.85. The stock got featured on our News Catalysts scanner on Mon, Jan 09, 2023 at 02:14 PM in the 'ACQUISITION' category. From Tue, Dec 27, 2022, the stock recorded 62.50% Up Days and 55.56% Green Days

About Albireo Pharma, Inc. (ALBO:NASDAQ)

Albireo Pharma Inc is a development-stage pharmaceutical company. It engages in the research and development of the drug reformulation technology. The company is engaged in the development an oral insulin to treat diabetes.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.